ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2019

Phase I Dose-Escalation Study of Once Weekly or Once Every Two Weeks Administration of High-Dose Sunitinib in Patients With Refractory Solid Tumors.

Maria Rovithi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.